These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15469551)

  • 1. The CARI guidelines. CMV disease and kidney transplant: prophylaxis for cytomegalovirus infection in patients following renal transplantation.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S27-31. PubMed ID: 15469551
    [No Abstract]   [Full Text] [Related]  

  • 2. The CARI guidelines. CMV disease and kidney transplant: pre-emptive treatment of cytomegalovirus.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S32-6. PubMed ID: 15469553
    [No Abstract]   [Full Text] [Related]  

  • 3. The CARI guidelines. CMV disease and kidney transplant: treatment of cytomegalovirus disease in renal transplant recipients.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S37-40. PubMed ID: 15469554
    [No Abstract]   [Full Text] [Related]  

  • 4. The CARI guidelines. CMV disease and kidney transplant: diagnostic tests for cytomegalovirus in renal transplantation.
    Caring for Australians with Renal Impairment (CARI)
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S23-6. PubMed ID: 15469550
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study.
    Moreno de la Higuera Díaz MA; Calvo Romero N; Sánchez-Fructuoso A; Conesa J; Marques Vidas M; Prats D; Barrientos Guzmán A
    Transplant Proc; 2007 Sep; 39(7):2231-2. PubMed ID: 17889147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN
    Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial cytomegalovirus prophylaxis with ganciclovir: no guarantee for prevention of late serious manifestations of CMV after solid organ transplantation.
    Zandberg M; de Maar EF; Hofker HS; Homan van der Heide JJ; Rosati S; van Son WJ
    Neth J Med; 2005 Nov; 63(10):408-12. PubMed ID: 16301763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
    Strippoli GF; Hodson EM; Jones C; Craig JC
    Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation.
    Sagedal S; Thiel S; Hansen TK; Mollnes TE; Rollag H; Hartmann A
    Nephrol Dial Transplant; 2008 Dec; 23(12):4054-60. PubMed ID: 18577532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced risk of cytomegalovirus infection in solid organ transplant recipients treated with sirolimus: a pooled analysis of clinical trials.
    Demopoulos L; Polinsky M; Steele G; Mines D; Blum M; Caulfield M; Adamkovic A; Liu Q; Harler MB; Hahn C; Singh A
    Transplant Proc; 2008 Jun; 40(5):1407-10. PubMed ID: 18589118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
    Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
    Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
    Hakkert A; Dykeman-Sharpe J
    CANNT J; 2003; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy.
    Nishida H; Ishida H; Tanaka T; Amano H; Omoto K; Shirakawa H; Shimizu T; Iida S; Toki D; Yamaguchi Y; Tanabe K
    Transpl Int; 2009 Oct; 22(10):961-9. PubMed ID: 19619177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
    Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
    Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients.
    Israni A; Krok K; Cohen D; Blumberg E; Bloom RD
    Transplant Proc; 2004 Dec; 36(10):3019-24. PubMed ID: 15686685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus disease with atypical presentation in a renal transplant patient: case report.
    Khosravi M; Nobakht A; Nikokar AR
    Exp Clin Transplant; 2006 Jun; 4(1):458-61. PubMed ID: 16827643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue.
    Potena L; Grigioni F; Magnani G; Branzi A
    Transplantation; 2009 Jan; 87(2):305-6; author reply 306-7. PubMed ID: 19155991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.